Lineage Cell Therapeutics, Inc. LCTX
0.99 USD 0.00 (+0.46%)
Nov 6, 2026, 10:37 AM EST
0.9808 Day range 1.01
0.88 52-week range 1.99
- YTD
- -40.86%
- 1 year
- -42.91%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 14.56M | 9.50M | 8.95M | 14.70M | 4.34M | |
| 14.41M | 9.16M | 8.27M | 13.97M | 2.92M | |
| -36.62M | -21.48M | -24.73M | -22.52M | -49.21M | |
| -63.53M | -18.61M | -21.49M | -26.27M | -43.02M | |
| -0.28 | -0.09 | -0.12 | -0.15 | -0.26 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 40.79M | 45.79M | 35.44M | 11.36M | 55.74M | |
| 112.58M | 113.22M | 101.02M | 123.66M | 174.54M | |
| 69.24M | 36.21M | 39.00M | 51.73M | 83.65M | |
| 2.42M | 2.51M | 2.95M | 3.90M | 2.80M | |
| 44.55M | 78.38M | 63.42M | 73.34M | 92.22M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -18.92M | -23.09M | -28.57M | 1.06M | -23.56M | |
| -13.46M | -2.31M | 46.45M | -46.16M | 9.74M | |
| 26.95M | 35.86M | 6.42M | 1.63M | 36.93M | |
| -522.00K | -565.00K | -674.00K | -413.00K | -340.00K | |
| -5.03M | 10.36M | 24.06M | -44.34M | 23.09M |